Theragen Etex aims the best in the world.
Theragen Etex Bio Institute is specialized genomics company developing innovative diagnosis tools and new drugs using the genomics and bioinformatics technologies. Theragen Etex Bio Institute’s world class analysis technologies are proven by number of high impact journal publications.
Proudly, we are the fifth organization in the world, which completed sequencing and assembly of an entire Human genome. In June 2013, we were recognized as the first group to identify genes that are related to Koran gastric cancer. In January 2014, we have secured the cover of the Nature Genetics with our research on the world’s first Minke Whale Genome.
We are providing genome-based customized research service, such as Genome, Transcriptome and Epigenome. In addition, we have personal genome service “HelloGene”, which is screening disease susceptibility, physical traits, drug sensitivity and so on.
Internationally, the first step has been started in the overseas markets with the personal genome analysis service contract with UNIMEX, the Philippines in 2011. Then, a joint venture for entry to the personal genome analysis service in Beijing, China named ‘Beijing Theragen Etex & Deyi Tech Co.,Ltd.’ has been established . Based on this, Asian genetic information and network have been organizing and gaining a foothold to move forward to global markets.
Based on these technologies and experiences, we are putting endless efforts to revolutionize personalized medicine and to become a global leader in human welfare and healthcare.
Theragen Etex is a drug development company that utilizes information from genome analysis. Our Bio Institute identifies potential genetic markers of various diseases. Information regarding genetic markers is used by our pharmaceutical division to develop new personalized drugs. We are investing an extensive amount of effort and resources to revolutionize personalized medicine by constructing genomic information databases using accumulated bioinformatics analysis capability and drug development technologies.
With drug research / pharmaceutical / distribution infrastructure, we will keep expanding our bio-business over the world.
National R&D based service
Personal Genome Service
Cancer Clinical Service
Theragen Etex Pharmaceutical
Advanced maternal age diagnostics
Drug Store chain
New drug development
Lui-dong, Yeongtong-gu Suwon-si Gyeonggi-do Korea
E : email@example.com
P : 82-31-888-9328
4th fl. AICT bldg. A, 145 Gwanggyo-ro, Yeongtong-gu, Suwon-si, Gyeonggi-do, Republic of Korea, 16229
Phone +82-31-888-9313 / Fax +82-31-888-9335